2025-05-01 06:48:37
Latest Post
Monarch Networth Capital IFSC Pvt. Ltd. receives Registered Fund Management Entity (Retail) License from IFSCA, GIFT City
Lucent Industries Ltd enters into partnership agreement with Clusterdev Technologies Pvt Ltd
South Indian Bank hosts Season 1 of National Co-lending Summit - SEED
Inox Green signs agreement for O&M of 675 MWp of solar projects
Union Bank of India Launches MSME & CASA Outreach Programs to pass on benefits of back to back RBI-MPC rate cuts and Deepen Customer Engagement
Stock Report
Zenotech Laboratories Ltd Q4FY25 PAT at Rs. 1.22 crore
Posted On : 2025-04-25 21:43:52( TIMEZONE : IST )
ZENOTECH LABORATORIES LTD. has reported Standalone financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 12.6241 crores during the period ended March 31, 2025 as compared to Rs. 11.6138 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. 1.2298 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 1.6928 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. 0.20 for the period ended March 31, 2025 as compared to Rs. 0.28 for the period ended December 31, 2024.
| Financials | Q4 FY2025 | Q3 FY2025 | % Change |
| Total Income | ₹ 12.6241 crs | ₹11.6138 crs |  8.70% |
| Net Profit | ₹1.2298 crs | ₹1.6928 crs |  -27.35% |
| EPS | ₹0.20 | ₹0.28 | -28.57% |
Financial Results (Q4 FY2025) - YoY Comparison
The company has reported total income of Rs. 12.6241 crores during the period ended March 31, 2025 as compared to Rs.9.4335 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.1.2298 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.0.6595 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.0.20 for the period ended March 31, 2025 as compared to Rs.0.11 for the period ended March 31, 2024.
| Financials | Q4 FY2025 | Q4 FY2024 | % Change |
| Total Income | ₹ 12.6241 crs | ₹9.4335 crs | 33.82% |
| Net Profit | ₹1.2298 crs | ₹0.6595 crs | 86.47% |
| EPS | ₹0.20 | ₹0.11 | 81.82% |
Financial Results (Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.44.5957 crores during the Financial Year ended March 31, 2025 as compared to Rs.41.8372 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.5.6129 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.8.2987 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.0.92 for the Financial Year ended March 31, 2025 as compared to Rs.1.36 for the Financial Year ended March 31, 2024.
| Financials | Year Ended FY2025 | Year Ended FY2024 | % Change |
| Total Income | ₹44.5957 crs | ₹41.8372 crs | 6.59% |
| Net Profit | ₹5.6129 crs | ₹8.2987 crs | -32.36% |
| EPS | ₹0.92 | ₹1.36 | -32.35% |
Shares of ZENOTECH LABORATORIES LTD. was last trading in BSE at Rs. 58.01 as compared to the previous close of Rs. 59.02. The total number of shares traded during the day was 12455 in over 146 trades.
The stock hit an intraday high of Rs. 59.98 and intraday low of 56.40. The net turnover during the day was Rs. 720198.00.
